🇦🇪 Praluent in United Arab Emirates

Praluent (ALIROCUMAB) regulatory status in United Arab Emirates.

Marketing authorisation

MOH

  • Status: likely_approved

Praluent in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United Arab Emirates

Frequently asked questions

Is Praluent approved in United Arab Emirates?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Praluent in United Arab Emirates?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.